Switch theme
Sign up to access all valuation multiples
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories, which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from Europe.
1998
21
LTM Revenue $1.6M
Last FY EBITDA -$18.8M
$11.1M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Durect has a last 12-month revenue (LTM) of $1.6M and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Durect achieved revenue of $2.0M and an EBITDA of -$18.8M.
Durect expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Durect valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $1.6M | XXX | $2.0M | XXX | XXX | XXX |
| Gross Profit | $1.5M | XXX | $2.0M | XXX | XXX | XXX |
| Gross Margin | 95% | XXX | 96% | XXX | XXX | XXX |
| EBITDA | n/a | XXX | -$18.8M | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | -927% | XXX | XXX | XXX |
| EBIT | -$19.9M | XXX | -$18.9M | XXX | XXX | XXX |
| EBIT Margin | -1258% | XXX | -931% | XXX | XXX | XXX |
| Net Profit | -$24.0M | XXX | -$8.3M | XXX | XXX | XXX |
| Net Margin | -1522% | XXX | -410% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of July 15, 2025, Durect's stock price is $1.
Durect has current market cap of $17.4M, and EV of $11.1M.
See Durect trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $11.1M | $17.4M | XXX | XXX | XXX | XXX | $-0.47 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of July 15, 2025, Durect has market cap of $17.4M and EV of $11.1M.
Durect's trades at 5.5x EV/Revenue multiple, and -0.6x EV/EBITDA.
Equity research analysts estimate Durect's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Durect has a P/E ratio of -0.7x.
See valuation multiples for Durect and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $17.4M | XXX | $17.4M | XXX | XXX | XXX |
| EV (current) | $11.1M | XXX | $11.1M | XXX | XXX | XXX |
| EV/Revenue | 7.0x | XXX | 5.5x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | -0.6x | XXX | XXX | XXX |
| EV/EBIT | -0.6x | XXX | -0.6x | XXX | XXX | XXX |
| EV/Gross Profit | 7.4x | XXX | n/a | XXX | XXX | XXX |
| P/E | -0.7x | XXX | -2.1x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -0.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialDurect's last 12 month revenue growth is -31%
Durect's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $1.0M for the same period.
Durect's rule of 40 is -321% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Durect's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Durect and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | -31% | XXX | -30% | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | -927% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | -321% | XXX | -958% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $1.0M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 511% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 1027% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Durect acquired XXX companies to date.
Last acquisition by Durect was XXXXXXXX, XXXXX XXXXX XXXXXX . Durect acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Durect founded? | Durect was founded in 1998. |
| Where is Durect headquartered? | Durect is headquartered in United States of America. |
| How many employees does Durect have? | As of today, Durect has 21 employees. |
| Who is the CEO of Durect? | Durect's CEO is Mr. James E. Brown,D.V.M.. |
| Is Durect publicy listed? | Yes, Durect is a public company listed on NAS. |
| What is the stock symbol of Durect? | Durect trades under DRRX ticker. |
| When did Durect go public? | Durect went public in 2000. |
| Who are competitors of Durect? | Similar companies to Durect include e.g. Julphar, Benevolent AI, Galapagos, Pharming. |
| What is the current market cap of Durect? | Durect's current market cap is $17.4M |
| What is the current revenue of Durect? | Durect's last 12 months revenue is $1.6M. |
| What is the current revenue growth of Durect? | Durect revenue growth (NTM/LTM) is -31%. |
| What is the current EV/Revenue multiple of Durect? | Current revenue multiple of Durect is 7.0x. |
| Is Durect profitable? | Yes, Durect is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
